论文部分内容阅读
本文论述了可东定近年来在临床上的应用和发展,该药是中枢α_2—受体激动剂,抑制中枢肾上腺素能神经系统,有效地治疗高血压。
This article discusses the clinical application and development of Kendong Dong in recent years. It is a central α 2 -receptor agonist that inhibits the central adrenergic nervous system and effectively treats hypertension.